• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Machine learning insights concerning inflammatory and liver-related risk comorbidities in noncommunicable and viral diseases

    2022-12-01 01:45:40AlfredoMartinezMartaAlonsoBernaldezDiegoMartinezUrbistondoJuanVargasNuiezAnaRamirezdeMolinaAlbertoDavalosOmarRamosLopez
    World Journal of Gastroenterology 2022年44期

    Alfredo Martinez,Marta Alonso-Bernaldez, Diego Martinez-Urbistondo, Juan A Vargas-Nuiez,Ana Ramirez de Molina,Alberto Davalos, Omar Ramos-Lopez

    Abstract The liver is a key organ involved in a wide range of functions, whose damage can lead to chronic liver disease (CLD). CLD accounts for more than two million deaths worldwide, becoming a social and economic burden for most countries.Among the different factors that can cause CLD, alcohol abuse, viruses, drug treatments, and unhealthy dietary patterns top the list. These conditions prompt and perpetuate an inflammatory environment and oxidative stress imbalance that favor the development of hepatic fibrogenesis. High stages of fibrosis can eventually lead to cirrhosis or hepatocellular carcinoma (HCC). Despite the advances achieved in this field, new approaches are needed for the prevention,diagnosis, treatment, and prognosis of CLD. In this context, the scientific community is using machine learning (ML) algorithms to integrate and process vast amounts of data with unprecedented performance. ML techniques allow the integration of anthropometric, genetic, clinical, biochemical, dietary, lifestyle and omics data, giving new insights to tackle CLD and bringing personalized medicine a step closer. This review summarizes the investigations where ML techniques have been applied to study new approaches that could be used in inflammatoryrelated, hepatitis viruses-induced, and coronavirus disease 2019-induced liver damage and enlighten the factors involved in CLD development.

    Key Words: Machine learning; Liver inflammation; Liver disease; Viral diseases; Comorbidity

    INTRODUCTION

    The liver is a key organ involved in relevant homeostatic metabolic and detoxifying human functions[1]. Thus, the liver is the epicenter of an organ-organ network weaving a series of complex interactions in the organism, which makes liver damage an underlying adverse condition in a whole set of diseases.Chronic liver disease (CLD) can be caused mainly by alcoholic liver-related dysfunctions, hepatitis B virus (HBV), hepatitis C virus (HCV), drug treatments, or non-alcoholic fatty liver disease (NAFLD), as recently updated to the term metabolic-associated FLD (Figure 1)[2,3]. Patients with liver-related diseases need frequent follow-ups and careful monitoring since CLD can eventually lead to cirrhosis or hepatocellular carcinoma (HCC) if not diagnosed on time for treatment or surgery. These CLD-related conditions have become a global burden, whose mortality associated rates have increased over the years reaching more than 2 million deaths worldwide[4].

    CLD is usually accompanied by an unhealthy inflammatory environment[5]. The immune response is a fundamental process to maintain homeostasis within the organism defense machinery and is characterized by the secretion of proinflammatory cytokines, like interleukin (IL)-1, tumor necrosis factor-α(TNF-α), and prostaglandin E2, in an acute manner in order to resolve sudden damage[5]. However, if sustained over time, these abnormal levels of inflammatory cytokines cause low-grade inflammation(LGI). LGI is a silent condition that predisposes to the development of metabolic and infectious diseases that has become a worldwide health issue[6]. Patients with CLD, such as non-alcoholic steatohepatitis(NASH), present impaired immune function, dysbiosis, insulin resistance (IR) and LGI, all of which can aggravate infectious disease progression and perpetuate excess of adipose tissue, are characterized by overstimulation of the production of adipose-derived inflammatory molecules[5,7-9].

    The liver also secretes important hepatokines that act as signaling proteins modulating functions in other organs and are involved in a wide range of conditions, such as IR and adipogenesis[1]. For instance, fibroblast growth factor-21 (FGF-21) is a mediator participating in glucose metabolism mainly secreted by the liver that modulates adipogenesis, while fetuins, liver-derived plasma proteins, are participating in metabolic impairment and inflammation[1]. A dysregulation in systemic cytokines prompts fat accumulation in hepatocytes, which in turn promotes local secretion of proinflammatory hepatokines, leading to liver steatosis and IR. In addition, immune cells also find difficulty in this inflammatory environment to exert their role appropriately. Persistent inflammatory signals over time also abnormally activate immune cells, impairing the body’s ability to fight infection, repair tissue damage, or recover from possible poisoning. Inflammation comes hand in hand with an increase in oxidative stress, a state characterized by an imbalance in favoring the accumulation of higher reactive oxygen (ROS) and nitrogen species. These molecules in unusual concentrations damage the cell and environmental milieu by promoting the expression of proinflammatory genes, resulting in a vicious cycle. Thus, CLD presents an oxidative atmosphere, probably linked to the proinflammatory state[10,11]. This environment is the perfect setting for the fibrogenic process to unfold, an underlying condition of CLD that is characterized by progressive accumulation of fibrillar extracellular matrix in the liver[12]. The stage of hepatic fibrosis has been associated with the risk of mortality and liver-related morbidity in patients with NAFLD[13], virus-induced hepatitis[14,15], and alcoholic-derived liver disease[16], eventually leading to HCC.

    In this context, infection by human hepatitis viruses (HHVs) is the most common cause of hepatitis,leading to the activation of the immune system, and the subsequent inflammatory response[17]. HBV and HCV acute infections can be resolved with antiviral and immune therapy. However, in a significant percentage they can progress to chronic hepatitis. This persistent infection can lead to comorbidities outside the liver, like arthritis, vasculitis, myalgia, and peripheral neuropathies[18]. Moreover, another new infectious disease appeared in late 2019 that can cause liver damage: Coronavirus disease 2019(COVID-19). COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)infection, and it has become a global health issue since its outbreak in 2020 was declared a pandemic.Beyond lung function, COVID-19 can affect a wide variety of tissues, like the gastrointestinal tract,kidneys, and liver, with an underlying adverse inflammatory environment[19]. This inflammatoryrelated condition has been strongly associated to metabolic status and worsening diseases like obesity,diabetes, and hypertension[7,20-22]. For instance, COVID-19 can increase hepatic lipid accumulation by mitochondrial and endoplasmic reticulum (ER) dysfunction or worsen NAFLD if it was already present.A recent systematic review depicted that the parameters normally used for liver impairment screening were significantly increased in COVID-19 patients[23], placing CLD as a risk factor for progressive and severe COVID-19[24,25].

    CLD is a global health problem, and new methods are needed to tackle this life-threatening condition.In this line, this review aims to explore machine learning (ML)-based approaches to manage CLD and develop biomarkers for diagnosis and prognosis. Its goal is to shed light on the factors involved in CLD to help health professionals in clinical management with the support of ML and identify new targets that can define therapeutic care lines in viral infections and non-communicable diseases (NCD), with an impact on liver functions with an inflammatory component. This includes the new disease, COVID-19.

    MECHANISMS BY WHICH NCD AND INFLAMMATORY/IR PHENOMENA CAN AFFECT LIVER FUNCTION

    The incidence of NCD, such as cardiovascular diseases and diabetes, has skyrocketed in the last decades, pressing authorities to establish developmental goals to achieve in the near future in terms of decreasing NCD-caused mortality[26]. Some of the risk factors that contribute to the development of NCD are excess of adipose tissue and high levels of glycemia. In this context, adipose tissue plays a key role in the development of FLD by secreting adipokines and other molecules, like free fatty acids (FFA)[8].

    An energy excess prompts fat accumulation in the organism and the subsequent dysregulation of this tissue. This is of relevance since an inflamed adipose tissue results in increased levels of FFA and proinflammatory cytokines, IR, and infiltration of macrophages in the liver by the activation of Th1 and Th17 cells[8]. FFA enter the liver through the portal vein and trigger a series of reactions. For instance,they serve as ligands to toll-like receptor-4 complex, stimulating the production of TNF-α through the activation of nuclear factor-kappa B, favoring an inflammatory environment. Moreover, the excess of fat drives the polarization state of this increased number of macrophages from anti-inflammatory M2 to proinflammatory M1 macrophages and prompts fat accumulation in the liver and IR[8]. Adiposederived macrophages also secrete inflammatory molecules, like TNF-α and IL-6, and adipokines, such as visfatin [also named nicotinamide phosphoribosyl transferase (NAMPT)]. NAMPT has gained relevance as a pivotal molecule linking adipose tissue and FLD. NAMPT is a pleiotropic molecule that can be found in an extracellular (eNAMPT) or an intracellular (iNAMP) form. Studies indicate that eNAMPT has enzyme and cytokine-like activity, stimulating the release of proinflammatory cytokines.Meanwhile, iNAMPT catalyzes the rate-limiting step in nicotinamide adenine dinucleotide (NAD+)formation. Because of this NAD+ boosting property, levels of iNAMPT have been proposed as beneficial for the homeostasis of the cell due to influencing the activity of NAD-dependent enzymes,such as sirtuins (SIRT). Remarkably, SIRT1 plays a key role in the liver by modulating the acetylation status of target molecules in lipid metabolism[27].

    Furthermore, IR is characterized by hyperglycemia and the subsequent hyperinsulinemia to counteract high glucose levels, being a risk factor for NCDs, particularly type 2 diabetes, where it has been closely linked to oxidative stress[28]. A normal insulin signaling pathway starts with the activation of the insulin receptor so that it can bind to phosphoinositide 3-kinase to ultimately activate protein kinase B (Akt). Activated Akt drives glucose entry into the cell by promoting GLUT4 expression and glycogen synthesis[29]. Oxidative stress impairs this signal transduction through many different mechanisms, like inhibiting the transcription factors insulin promoter factor 1 and peroxisome proliferator-activated receptor gamma, which mediate insulin and GLUT-4 expression, respectively.Moreover, under hyperglycemic conditions, fetuin A hepatokine inhibits the insulin receptor and promotes inflammation, while FGF-21 inhibits lipid accumulation and increases insulin sensitivity.Dysregulation of this hormones, together with oxidative stress imbalance, lead to impaired insulin signaling[30].

    The metabolic conditions underlying the development of NCD are complex, and they often reinforce each other, perpetuating an inflammatory environment and oxidative stress imbalance. As the orchestrating organ, these processes converge in the liver, affecting metabolic functions and setting the basis for the onset of the fibrogenic process characteristic of CLD.

    MECHANISMS BY WHICH VIRAL INFECTIONS AND INFLAMMATORY/IR PHENOMENA CAN AFFECT LIVER FUNCTION

    Persistent virus-associated liver damage can progress to CLD, which pressures health systems with a big social and economic burden. Although lots of resources have been invested to study the molecular mechanisms that mediate this process, results are diverse and still under investigation by the scientific community. HHVs directly infect hepatocytes, and the internalization into the cell is believed to happen by endocytosis, requiring the interaction with several host cell factors[17]. However, viral entry of HBV and HCV within hepatocytes is unclear, and further research is needed to elucidate this question.Sodium taurocholate co-transporting polypeptide was recently identified as an HBV receptor that would mediate HBV cell entry[31]. In the case of HCV, specific intercellular adhesion molecules appear key to cell adhesion and subsequent internalization[32].

    Regarding HBV and HCV replication, it has been found that liver X receptor-α (LXR-α) plays a key role. LXR-α is a transcription factor whose activation triggers the expression of different genes that directly or indirectly modulate these viruses’ replication as well as the lipid and inflammatory alterations associated to CLD[33]. This inflammation is also mediated by the nucleotide-binding oligomerization domain-like receptor protein 3, which is activated by the abnormal production of ROS after a viral infection occurs in the liver. This ROS increase is associated with a decreased expression of nuclear factor-e2-related factor-2, a transcription factor that regulates ROS/recepteur d’origine nantais balance by maintaining redox homeostasis. These alterations compromise the normal state of the cell,laying the foundations on which the fibrotic process of CLD begins[11].

    In the case of COVID-19, the mechanisms by which liver damage can occur are more unclear, but it is widely accepted that inflammation plays a huge role. This infection can trigger an exaggerated immune response leading to an uncontrolled cytokine release, also known as a “cytokine storm”. It is characterized by abnormal levels of IL-6, IL-1, C-C motif chemokine ligand (CCL)-5, chemokine (C-X-C motif)ligand (CXCL)-8, CXCL-1, and TNF-α among others[19]. This inflammatory cascade affects bile duct function since cytokines like TNF-α, IL-1, and IL-6, can induce hepatocellular cholestasis by downregulating hepatobiliary uptake and excretory systems[34].

    Furthermore, the presence of this inflammatory environment can upregulate the expression of angiotensin converting enzyme 2 (ACE2)receptor in different tissues, like the adipose tissue and the liver[35-39]. This is of relevance since ACE2 receptors are the main cell entrance of the SARS-CoV-2 virus, and they are present in different tissues. Particularly in the liver, the cholangiocytes (characteristic cells of the bile duct)[40], as well as liver vascular endothelial cells[41], express ACE2 receptors.Hepatocytes and cholangiocytes are permissive to the SARS-CoV-2 virus, mediating subsequent entrance into the liver[42]. Several studies have found thatACE2expression in hepatocytes is increased under hypoxia[43], a frequent condition in COVID-19 patients, and fibrotic conditions[44]. Besides ACE2 receptors, transmembrane serine protease 2 (TMPRSS2) and paired basic amino acid cleaving enzyme (FURIN) have been noted as significant for infection in the liver[45,46]. In this context,ACE2expression is increased in patients in HCV-related cirrhosis[44], whereasTMPRSS2andFURINexpression are upregulated in patients with obesity and NAFLD[47]. Moreover, infection by SARS-CoV-2 increases glucose-regulated protein 78 and 94, two biomarkers of ER stress[48,49], and impairs mitochondrial function[50]. This process is of interest since this state has been associated withde novolipogenesis in hepatocytes[51], which could eventually lead to steatosis in these patients.

    The use of therapeutic drugs can be another underlying cause of liver damage[3]. Because of detoxifying functions, the liver is subject to drug-induced damage coming from a wide range of approved drugs. Oncology drugs account for most hepatotoxicity cases, followed by those used for infectious diseases[3]. Since the beginning of the COVID-19 pandemic, a wide range of different treatments (antivirals, antibiotics, antimalaria, or corticosteroids) have been used in the absence of an efficient drug to treat severe infections. This pharmacological administration could explain that druginduced liver injury appears in nearly 25% of COVID-19 patients[23], a consequence to consider when addressing liver damage in this disease.

    ML APPROACHES IN INFLAMMATORY AND LIVER-RELATED COMORBIDITIES IN NONCOMMUNICABLE AND VIRAL DISEASES

    Despite all the advances in the mechanisms driving the onset of these diseases, new techniques to detect innovative biomarkers for diagnosis and prognosis as well as to discover novel drugs are needed, for example artificial intelligence (AI). AI seeks to mimic human behavior, and within this science, ML is the most common approach[52]. The advances in computational science in the last decades have permitted the development of powerful algorithms based on this science. ML algorithms are particularly relevant for biological research because they allow the processing and integration of the huge amount of data that the latest advances in this field have brought by applying statistical methods to enable machines to improve experiences. This methodological approach can be categorized into two big groups: Supervised and unsupervised learning. In supervised algorithms, data is tagged in order to train the algorithm and fit it appropriately, whereas if it is unsupervised, the algorithm learns patterns from unlabeled data[53]. ML algorithms are generally assessed by simple methodologies like sensitivity,specificity, and accuracy. While sensitivity evaluates the proportion of true positives correctly identified,specificity evaluates the proportion of true negatives. Meanwhile, the accuracy value indicates the number of times the model is correct[54].

    Supervised algorithms can be divided into two categories depending on the purpose: Prediction, in which the algorithm is fed and trained predictive models to data; or classification, which consists in clustering data within explanatory groups[55,56]. Predictive algorithms are based on regression models,and the most used are linear and logistic regression (LR), support vector machine (SVM), support vector regression (SVR), extra tree regression (ETR), artificial neural networks (ANN), and decision trees (DT).Regression models analyze the influence of one or multiple variables on a nominal or ordinal categorical outcome. ANN are more complex mathematical models (deep learning algorithms) that mimic the brain neural network, like the convolutional neural network (CNN), in which an input is fed through a hidden layer of many different well connected and structured nodes to produce a final output. In deep neuronal network (DNN) models, a great number of hidden successive layers use the output from the previous layer as input in a more complex algorithm. DT can also classify data, like random forest (RF)or gradient boosting (GB) models. Instead of minimizing error, these models determine thresholds derived from input data, assigning weight values to variables. Other models of classification are the Ada-Boost, Bayesian network (BN), Na?ve Bayes (NB), K-Nearest Neighbors (KNN), and linear discriminant analysis (LDA) that group data into clusters[55,56]. All these models can shed light into biological questions and are normally used indistinctively to obtain the best performance with the same dataset. For instance, Mijwil and Aggarwal[57] analyzed and compared 7 ML algorithms to predict appendix illness in the same dataset, revealing that certain models performed better than others,allowing for higher accuracy and results.

    In FLD, the common techniques used in diagnostics are based on techniques like ultrasonography and magnetic resonance imagining (MRI). These methods are subjective, and the informed outcome mainly relies on the interpretation of the professional carrying out the procedure. Several investigations have studied the implementation of ML in order to classify FLD and other liver diseases by using images from ultrasounds, computed tomography (CT), and MRI[58,59]. However, the downside of this approach is that the quality of the images differs from one another because of several factors, such as equipment precision and interpersonal differences, for instance. Therefore, there is a need for ML approaches to help in image segmentation, and some authors have already implemented this technique to improve clinical practice[60,61].

    Moreover, ML can help with the integration of more complex information beyond imaging to study and diagnose liver diseases since patients with CLD in the developmental phase require frequent follow-ups to check the progress of the disease and early detection changes in the diagnosis[58]. For example, patients with HHV-induced CLD are normally on antivirals. However, there is no consensus or guidelines about when to stop antiviral therapy or even if quitting these drugs will increase HCC risk. Therefore, new approaches need to be established to classify and prevent the development of more severe illnesses, like cirrhosis or cancer. In this line, ML approaches can be used to measure liver fibrosis, optimize diagnosis, and predict disease progression of CLD[62]. Table 1 summarizes selected studies that have used ML for these purposes, which have been collected for this review, and Table 2 summarizes the most repeated inputs from all compiled ML models along with the most repeated predictive results for the main four inflammation-related liver conditions.

    ML in inflammation-related liver disease

    In recent years, promising results have been found when applying ML approaches in CLD. Regarding prevention, Fialokeet al[63] screened 108139 patients to identify those diagnosed with benign steatosis and NASH, a type of NAFLD, train ML classifiers for NASH and healthy (non-NASH) populations, and predict NASH disease status on patients diagnosed with NAFLD according to aspartate transaminase(AST), alanine transaminase (ALT), and platelet (PLT) levels. In this line, another study detected body mass index (BMI), triglycerides (TG), gamma-glutamyl transpeptidase (GGT), ALT, and uric acid as the top 5 features contributing to NAFLD, with the BN model performing the best[64]. Accordingly, Yipet al[65] selected TG, ALT, white blood cell count, high-density lipoprotein cholesterol (HDL-c), glycated hemoglobin A1c (HbA1c), and the presence of hypertension as the six variables to build ML models, of which Ada-Boost outperformed the others individually and described the NAFLD status in 922 subjects.

    More recently, Peiet al[66] designed a ML model that integrated medical records as a clinical variable to classify FLD. Concretely, they selected the variables of age, height, BMI, hemoglobin, AST, glucose,uric acid, low-density lipoprotein cholesterol (LDL-c), alpha-fetoprotein, TG, HLD-c, and carcinoembryonic antigen. They tested six different ML models in 3419 participants, of which 845 were diagnosed with FLD: LR, RF, ANN, KNN, extreme gradient boosting (XGBoost) (a type of GB model), and LDA.Results from these authors showed that the XGBoost model had the highest performance, followed by LR and ANN, to predict the risk of FLD. BMI, uric acid, and TG levels were the top three variables associated to FLD risk across the six analyzed models.

    When it comes to diagnosis and treatment, several ML models have been tested for different purposes obtaining good specificity, sensitivity, and accuracy values[62]. For example, to determine the stage of liver fibrosis, some authors have used CT images processed by segmentation algorithms. Choiet al[67] used CNN upon CT images, whereas Chenet al[68] employed RF, KNN, SVM, and the NB classifiers with real-time tissue elastography imaging, age, and sex as feeding variables. In both cases,the ML approach outperformed the classical methods. Regarding treatment, different ML models have been used to define the best therapy for liver diseases such as carcinomas and virus-induced hepatitis.Jeonget al[69] used DNN to classify intrahepatic cholangiocarcinoma susceptible to adjuvant therapy following resection according to laboratory and clinicopathological markers and found it more accurate than the commonly used staging system.

    Wübboldinget al[70] studied the prediction of early virological relapse analyzing soluble immune markers using supervised ML approaches like KNN, RF, and LR. This study showed that IL-2,monokine induced by interferon γ/CCL9, RANTES/CCL5, stem cell factor, and TNF-related apoptosisinducing ligand in combination were more reliable in predicting virological relapse than viral antigens.In the same way, researchers have used ML classifiers to explore new methods able to better predict prognosis of liver diseases[71-74]. The weighted variables are usually CT images and/or biochemical parameters that involved invasive and costly methods. However, researchers have recently proposed volatile organic compounds as new biomarkers for progression and prognosis of liver disease. These researchers monitored isoprene, limonene, and dimethyl sulfide concentrations from a breath sample in liver patients compared to healthy subjects. They used regression ML models (LR, ETR, SVR, and RF) to demonstrate that these approaches together with breath profile data can predict clinical scores of liver disease[75]. These findings are promising and open the way for new, safe, and non-invasive approaches to study liver function and for diagnosis purposes.

    ML methods have been employed when studying the comorbidities of liver-related diseases, like obesity, diabetes, and cardiovascular diseases[53,55,76]. For example, ML algorithms have been built to study the risk factors associated to overweight and obesity development, showing that BMI, age, dietary pattern, blood test results, socioeconomic status, and sedentarism were key factors when studying excess of adipose tissue[77]. In this line, further research has revealed by ML techniques that the minutes devoted to physical activity in one week[78], as well as specific species of gut microbiota[79],are also crucial for obesity prediction. ML algorithms have also elucidated the risk factors of childhoodobesity, of which parental BMI and the upbringing environment play a huge role[80-82]. Furthermore,researchers have observed by training a multivariate LR model with a dataset of 3634 children and adolescents’ vitamin intake that vitamins A, D, B1, B2, and B12 were associated in a negative manner with obesity in this cohort[83]. These results are of interest since new insights are needed to discover novel targets to tackle comorbidities that affect liver function.

    Table 1 Summary of machine learning articles studying virus and inflammatory-related liver damage

    [75]function-related scores(MELD, APRI, CTP)using breath biomarkers compared to n = 17,liver patients metric data, blood biomarkers, breath analysis ETR 0.82, and 0.85 for CTP score, APRI score, and MELD,respectively, by ETR dimethyl sulfide can be potential biomarkers for liver disease Butt et al[85]To diagnose the stage of hepatitis C n = 968, patients with HCV Age, anthropometric data, blood biomarkers, and histological staging ANN, RF,SVM,XGBoosting 98.89% precision by ANN The model performed better than previously presented models by other authors Wei et al[87]To predict HBV and HCV-related hepatic fibrosis n = 490, HBV patients; n= 254, and 230 HCV patients Age, BMI,analytical data(FIB-4 score), and liver biopsy GB, DT, RF AUROC of 0.918 by GB GB outperformed the FIB-4 predictive score Barakat et al[89]To predict and stage hepatic fibrosis in children with HCV n = 166, children with CHC Analytical data(APRI and FIB-4 scores)RF AUCs of 0.903 for any type of fibrosis RF outperformed FIB-4 and APRI predictive score Konerman et al[88]To predict progression of HCV n = 72683, veterans with CHC Age, BMI,demographic, and blood biomarkers(APRI score)CS and LGT Cox and boosting AUROC of 0.830 and 0.77 sensitivity by LGT boosting model for 1 yr follow-up APRI and PLT count were top predictors in the LGT boosting model Wong et al[86]To predict HCC in patients with CVH n = 86804, CHV patients, of which 6821 with HCC Age, sex, clinical data, and blood biomarkers LR, RIDGE regression,AdaBoosting,RF, DT AUROC of 0.992 and 0.837 by RF in training and validation cohort,respectively ML models obtained better AUROCs than HCC traditional risk scores Feldman et al[91]To predict DAA therapy duration in hepatitis C n = 3943, HCV patients with sofosbuvir/ledipasvir as the first course of DAA,of which n = 240,received the prolonged DAA treatment Age, sex, and clinical data(including hepatitis C record data)XGBoosting,RF, SVM AUC of 0.745 by XGBoosting Results showed age,comorbidity burden, and type 2 diabetes status as new predictors for DAA therapy duration Kamboj et al[92]To predict repurposed drugs for HCV n = 17968 HCV molecular fingerprints Experimentally validated small molecules from the ChEMBL database with bioactivity against HCV NS3,NS3/A4, NS5A and NS5B proteins SVM, ANN,KNN, RF R2 value of 0.92 by SVM Results identified more than 8 repurposed treatments anti-HCV Tian et al[93]To predict HBsAg seroclearance n = 2235, patients with CHB, of which 106 achieved HBsAg seroclearance Age, BMI,demographic and clinical data, and blood biomarkers LR, RF, DT,XGBoosting AUC of 0.891 by XGBoosting Level of HBsAg followed by age and HBV DNA were the top predictors Chen et al[94]To predict HBVinduced HCC using quasispecies patterns of HBV n = 307, CHB patients; n= 237, HBV-related HCC patients rt nucleic acid and rt/s amino acid sequences SVM, RF,KNN, LR AUC of 0.96, and accuracy of 0.90 by RF HBV rt gene features can efficiently discriminate HCC from CHB Mueller-Breckenridge et al[95]To classify HBeAg status in HBV patients using virus full-length genome quasispecies n = 352, CHB untreated patients Matrix of allele frequencies (0.1-0.99) and the associated HBeAg status RF Range balanced accuracy of 0.8-1 n1896GA, n1934AT,n1753TC mutants were the highest-ranking variables Kayvanjoo et al[96]To predict HCV interferon/ribavirin therapy outcome based on viral nucleotide attributes n = 76, gene attributes HCV nucleotide attributes DT, SVM, NB,DNN Accuracy of 84.17% by SVM in responder vs relapser of subtype 1b sequences Dinucleotides UA and UU were top predictors in the combination treatment outcome Li et al[98]To distinguish influenza from COVID-19 patients n = 398, COVID-19 and influenza cases Age, sex, blood biomarkers,clinical data, and CT and X-ray scans XGBoosting,RF, and LASSO and RIDGE regression models AUC of 0.990,sensitivity of 92.5% and a specificity of 97.9% by XGBoosting Age, CT scan result, and temperature were top three predictors Bhargava et al To detect novel n = 31454, images CT or X-ray scans KNN, SRC,99.14 of accuracy SVM model classified with

    [99]COVID-19 and discriminate between pneumonia acquired from nine distinct datasets of COVID-19 patients ANN, SVM by SVM the highest recognition rate the images as normal,pneumonia, and COVID-19 positive Bennett et al[97]To predict early severity and clinically characterize COVID-19 patients n = 174568, patients with a positive lab test for COVID-19 Age, sex,demographic,anthropometric and clinical data,and blood biomarkers RF, LR,XGBoosting AUROC of 0.87 by XGBoosting Age, oxygen respiratory rate, and blood urea nitrogen were ranked as top predictor for severity outcome Günster et al[100]To identify independent risk factors for 180-d allcause mortality in COVID-19 patients n = 8679, hospitalized COVID-19 patients Age, sex, BMI, and clinical data LR AUC of 0.81 A high BMI and age were strong risk factors for 180-d all-cause mortality, while female sex was protective Deng et al[101]To identify clinical indicators for COVID-19 n = 379, patients, 62 with COVID-19 and 317 with pneumonia Age, sex,demographic and clinical data, and blood biomarkers EBM AUC of 0.948 Variables grouped under liver function was top the predictor category for COVID-19 prediction Lipták et al[102]To identify gastrointestinal predictors for the risk of COVID-19-related hospitalization n = 680, patients Age, sex, clinical data, and blood biomarkers RF AUC of 0.799 AST was top predictor for hospitalization Elemam et al[103]To identify immunological and clinical predictors of COVID-19 severity and sequelae n = 37, COVID-19 patients; n = 40, controls Age, sex, BMI,clinical data, and blood biomarkers Stepwise linear regression AUC of 0.93 for cytokines as predictors. AUC of 0.98 for biochemical markers as predictors IL-6 and granzyme B were top potential predictors of liver injury in COVID-19 patients Mashraqi et al[104]To predict adverse effects on liver functions of COVID-19 ICU patients n = 140, COVID-19 patients admitted to ICU Blood biomarkers and existence of liver damage SVM, KNN,ANN, NB, DT AUC of 0.857 and precision of 0.95 by SVM AST and ALT were top predictors of liver damage in these patients Soltan et al[106]To evaluate a laboratory-free COVID-19 triage for emergency care n = 114957, emergency presentations prior to the global COVID-19 pandemic and n = 437,COVID-19 positive Blood biomarkers,blood gas, and vital signs LR,XGBoosting,RF AUROC range of 0.9-0.94 by XGBoosting for datasets The model could effectively triage patients presenting to hospital for COVID-19 without lab results Gao et al[111]To predict mortality in patients with alcoholic hepatitis n = 210, alcoholic hepatitis patients Age, clinical data,blood biomarkers,and omics data sets (metagenomics,lipidomics, and metabolomics)GB, LR, SVM,RF AUC of 0.87 by GB for 30-d mortality prediction using the dataset combining clinical data,bacteria and MetaCyc pathways and for and 90-d mortality prediction using the fungi dataset The model performed better than the currently used MELD score NASH: Non-alcoholic steatohepatitis; NAFLD: Non-alcoholic fatty liver disease; CHB: Chronic hepatitis B virus infection; HCC: Hepatocellular carcinoma;HCV: Hepatitis C virus; CHC: Chronic hepatitis C virus infection; CVH: Chronic viral hepatitis; RF: Random forest; DT: Decision trees; LR: Logistic regression; SVM: Support vector machine; KNN: K-nearest neighbors; BN: Bayesian network; NB: Na?ve Bayes; AODE: Aggregating one-dependence estimators; FLD: Fatty liver disease; ANN: Artificial neural networks; LDA: Linear discriminant analysis; CNN: Convolutional neural network; DNN: Deep neuronal network; SRC: Sparse representative classifier; EBM: Explainable boosting machine; CS: Cross-sectional; LGT: Longitudinal; HBsAg: Hepatitis B surface antigen; HBeAg: Hepatitis B virus e antigen; BMI: Body mass index; ALT: Alanine transaminase; AST: Aspartate transaminase; APRI: Aspartate transaminase/platelet ratio index; COVID-19: Coronavirus disease 2019; CT: Computed tomography; GB: Gradient Boosting; AUC: Area under the curve;AUROC: Area under the receiver operating characteristic curve; ICU: Intensive care unit; IL-6: Interleukin 6; DAA: Direct-acting antiviral; MELD: Model for end-stage liver disease; TG: Triglycerides; HbA1c: Glycated hemoglobin A1c; ICC: Intrahepatic cholangiocarcinoma; ML: Machine learning; ETR: Extra tree regression; AJCC: American Joint Committee on Cancer; CXCL: chemokine (C-X-C motif) ligand; CCL: C-C motif chemokine ligand; SVR: Support vector regression; MIG: Monokine induced by interferon γ; SCF: Stem cell factor; TRAIL: Tumor necrosis factor-related apoptosis-inducing ligand; PLT:Platelet; GGT: Gamma-glutamyl transpeptidase; HDL-c: High density lipoprotein cholesterol; FIB-4: Fibrosis-4; HBV: Hepatitis B virus; TACE:Transarterial chemoembolization; BCLC: Barcelona Clinic Liver Cancer.

    Table 2 Summary of the most repeated inputs of the machine learning models with the most repeated predictor outcomes for the four main inflammatory-related liver conditions

    ML in hepatitis virus-induced liver damage

    HBV and HCV infections can dangerously become chronic if not treated early and with the right treatment[84]. While scientists are still relentlessly working on an effective vaccine against HCV, a good and efficient diagnosis is key to prevent chronic HCV infection (CHC), and ML algorithms have been elucidated for this purpose. Thus, Buttet al[85] designed an ANN model and trained it with a dataset of 19 variables, among which age, sex, BMI, transaminase, and PLT count levels were included. The algorithm was able to better identify the stage of hepatitis C compared to other XGBoost, RF, and SVM models tested by other researchers with a higher precision rate and a decreased miss rate.

    ML algorithms have been applied and compared to traditional methods used to follow HHV-induced advanced liver disease[86-88]. For instance, Weiet al[87] used a GB model trained with the same variables that the formula fibrosis-4 (FIB-4) uses, which are age, AST, ALT and PLT levels in a cohort of 490 HBV patients, and two cohorts of HCV patients (n= 240 each). The GB model outperformed FIB-4 score in classifying hepatic fibrosis and the existence of cirrhosis. Barakatet al[89] designed an RF model that also outperformed the FIB-4 score, as well as the AST/PLT ratio index (APRI), for prediction and staging of fibrosis in children with hepatitis C. In this line, data of 72683 veterans with CHC were used to predict the progression of the disease. GB models were used and compared with cross-sectional or linear models fed with variables like transaminases levels, alkaline phosphatase (ALP), PLT, AST, APRI,albumin, bilirubin, glucose, white blood cells, and BMI were included in the dataset. Results showed that APRI, PLT, AST, albumin, and AST/ALT ratio were the best predictors for featuring CHC progression[88].

    Regarding therapy, CHC can be effectively treated with direct-acting antiviral (DAA) therapy, a novel treatment that targets viral non-structural proteins. Although it has null side effects compared to standard treatment, it has some downsides. Treatment failure in a low percentage of the cases, a very high cost, and no treatment duration established[90]. New methods to define this therapy duration are needed to optimize adherence and success. Feldmanet al[91] studied the prediction of DAA treatment duration in hepatitis C patients using XGBoost, RF, and SVM models. They used the dataset of 240 patients with prolonged first course of DAA against another dataset of 3478 patients on standard duration. Age, sex, comorbidities, and previous hepatitis C treatment record were considered. The predictive model constructed with XGBoost obtained the best performance in predicting prolonged DAA treatment, in which the presence of cirrhosis, type 2 diabetes, age, HCC, and previous standard treatment were the most determining variables. Meanwhile, Kambojet al[92] used ML approaches in the search of repurposed drugs that could target non-structural proteins, developing regression-based algorithms able to identify inhibitors of these proteins, and proposing new drugs to test in CHC.

    A huge milestone when treating chronic HBV infection (CHB) is seroclearance of HBV surface antigen (HBsAg)[84]. It has been demonstrated that seroclearance of HBsAg is associated to a better prognosis in CHB. Some authors used ML models to predict HBsAg seroclearance in a cohort of 2235 patients, of which 106 achieved it. They used XGBoost, RF, and LR, among other models, and tested a total of 30 categorical and continuous variables, including sex, drinking history, initial diagnosis and treatment, age, BMI, and serum and radiological indicators. Results revealed that the XGBoost model showed the best predictive performance, indicating that HBsAg levels were the best predictor for HbsAg seroclearance, followed by age, and the DNA level of HBV[93].

    Interestingly, ML has also contributed to personalized medicine in this field. HHVs evolve and adapt to different cellular environments in order to escape immune responses and drugs to survive. These adaptations rely on high mutagenetic activity, especially within the target genes of antivirals. Regarding HBV, Chenet al[94] used ML to identify patients with HCC or CHB based solely on genetic differences and found that the RF model impressively discriminated both cases based on thertgene sequence of HBV. Moreover, Mueller-Breckenridgeet al[95] ultra-deep sequenced 400 HBV samples and used an RF model to classify the status of a particular HBsAg according to the novel viral variants encountered.Results showed five genotypes that could benefit from personalized healthcare. In the case of HCV,Kayvanjooet al[96] built several ML algorithms and trained them with two datasets of respondersvsnon-responders of antiviral therapy in HCV infection caused by two different strains. These investigations reported novel genetic markers that could predict therapy response with high accuracy. These results are very promising since they contribute to bringing personalized medicine to the public system.

    ML in COVID-19-induced liver damage

    A recent systematic review depicted that the parameters normally used for liver impairment screening were significantly increased in COVID-19 patients[23]. Particularly, several studies showed that levels of AST and/or ALT can increase in these patients up to 20%, bilirubin up to 14%, ALP up to 6%, and GGT levels up to 21%. Prothrombin is a protein synthesized in the liver that results in thrombin, a protein with a critical role in coagulation function. Prolonged prothrombin is a symptom of decreased production of coagulation factors, characteristic of liver disease. For this reason, the prolonged prothrombin time (PT) is another parameter usually checked when screening for liver injury, and it has been described that COVID-19 patients present nearly a 10% increase in PT[23]. Besides biochemical alterations, COVID-19 illness can lead to hypoxemia, impaired cardiac function, and secondary damage due to multiple organ dysfunction, which can result in liver injury in patients with or without prior liver disease. Therefore, new insights of the relationship between this recent infectious illness and liver disease are expected.

    The use of ML approaches has been encouraged by the National COVID Cohort Collaborative Consortium for early detection, prediction, and follow-up of severe COVID-19 cases since the pandemic started[97]. For instance, some researchers used the XGBoost approach and found that age, CT scan result, body temperature, lymphocyte levels, fever, and coughing can classify influenza patients from COVID-19 patients[98]. Bhargavaet al[99] tried different ML approaches to detect novel COVID-19 and discriminate between pneumonia using CT andX-ray scans as inputs. These authors pre-processed the images by normalization and then segmented them by fuzzy c-means clustering. Results showed that the SVM model was the one that better classified patients in COVID-19 positive, pneumonia, and healthy groups, obtaining a very high accuracy.

    In this same line, obesity and liver disease were identified as risk factors for higher clinical severity in a cohort of 174568 adults with severe acute respiratory syndrome associated with SARS-CoV-2 infection by a multivariable LR model[97]. Interestingly, a German study of 8679 patients used an LR model and identified liver disease and BMI as determinant risk factors for 180-d all-cause mortality in hospitalized COVID-19 patients[100]. A case-control study with COVID-19 patients compared to patients with community-acquired pneumonia showed how, by applying a GB model, the category of liver function appeared as one of the top systematic predictors for COVID-19 risk factors, with albumin, total bilirubin, and ALT among the most important input variables[101]. Furthermore, a study with 710 enrolled patients diagnosed with COVID-19 identified AST levels as the top predictor for COVID-19-related hospitalization based on an RF algorithm, followed by age and diabetes mellitus[102].

    A stepwise linear regression model identified IL-6 and granzyme B as potential predictors of liver dysfunction, characterized by an elevation in the levels of ALT and/or AST[103]. Other authors designed a model for detecting liver damage testing different ML approaches with laboratory parameters as the input variables. SVM was the model with the best accuracy, and AST and ALT levels were the variables with the best predictive scores[104]. In this context, the newest version of the CURIAL model was developed to identify COVID-19 patients using vital signs, blood gas, and laboratory blood tests. It showed greater sensitivity, making this model a potential emergency workflow[105,106]. All these ML-based methods would dramatically improve the time to diagnosis, free hospital laboratories and rooms of potential positive subjects, and reduce costs if implemented in the public health system.

    AI has also been employed to discover potential efficient new drugs to tackle SARS-CoV-2 infection[107]. Baricitinib is a drug initially approved for rheumatoid arthritis that was selected by ML as a potential drug to treat COVID-19. Researchers proved the anti-inflammatory and antiviral properties of this drug in human liver spheroids infected with live SARS-CoV-2 to check any potential drug-induced liver injury[107]. Due to the good results, researchers moved on to a clinical trial where they tested baricitinib in a few COVID-19 patients. Levels of liver enzymes were not altered, except for a transient increase in liver aminotransferases in all patients that remitted in the following 72 h without interrupting treatment. The authors stated that this might be reflective of disease severity rather than a drug-induced injury, showing overall good tolerance and results in this pilot study[108]. In summary,ML approaches support liver biochemistry as a prognostic tool in COVID-19 disease.

    PERSONALIZED MEDICINE IN LIVER-RELATED DISEASES SUPPORTED BY ML

    In the early 21stcentury, the Human Genome Project started the genomic era in which new disciplines like precision medicine appeared. Precision medicine aims to deliver targeted treatments based on a group of individual factors that greatly influence the onset and progression of a disease, like omics sciences. This approach covers a great number of patients, overcoming potential adverse effects and ensuring effectiveness of the treatment. In this context, computational advances have greatly contributed to the escalation of this science by lowering the costs of omics analysis and allowing the processing and integration of an enormous amount of data based on ML algorithms (Figure 2).

    ML has permitted the development of diagnostics and therapeutics based on the integration of omics data (genomics, epigenomic, transcriptomics, proteomics, metabolomics, and metagenomics) with clinical data. The ultimate goal is to bridge these omics data with the phenotype to bring molecular accuracy to the diagnosis, treatment, prognosis, and recurrence process of a pathological condition. This methodology has been used in a wide range of diseases in the search for more efficient and effective approaches, like heart and liver diseases[109,110]. For example, ML algorithms fed with omics data have been able to predict mortality in patients with alcoholic hepatitis. In this study, routine clinical variables of 210 patients with this disease were used to build six different datasets to assess mortality at 30 d and 90 d. Five different ML models were tested, obtaining the best performance in predicting 30-d mortality with a GB model using bacteria, MetaCyc pathways, and clinical data, as well as LR using viral and clinical data[111].

    In hepatitis B, it has been found that ML algorithms can be very useful in assessing HBV-associated HCC progression. Yeet al[112] analyzed 67 HBV-positive HCC samples with or without intrahepatic metastases and discovered key genes for metastatic progression and survival training ML models. The majority of them were inflammatory or related to the inflammation process, like IL-2 receptor and osteopontin, which encodes an extracellular cytokine ligand whose overexpression favors metastasis.These authors were able for the first time to draw a molecular signature useful to classify metastatic HBV-HCC patients, opening the way for early detection and new treatments to increase patient survival. In hepatitis C, the CC and CT genotypes of the rs12979860 polymorphism in theIL28Bgene have been associated with liver fibrosis progression, being able to predict antiviral treatment effectiveness[113].

    Moreover, ML algorithms have allowed the diagnosis of advanced liver fibrosis according to the rs12979860 genotype with higher performance compared to APRI and FIB-4 scores[114]. In this study,patients were divided into two groups according to HCV-related liver fibrosis stage: None to moderate fibrosis (n= 204); or with advanced fibrosis (n= 223). ML algorithms revealed theIL28Bgenotype as the first predictor, while the second predictor depended on the mentioned genotype. For instance, in CT patients, PLT, albumin, and age were the determining variables, while for patients with the TT genotype, white blood cell count was the decisive feature to assess advanced fibrosis probability.

    ML approaches have also helped to categorize obesity in different subtypes based on metabolic status[115-117]. For example, Masiet al[115] studied a cohort of 2567 subjects suffering from obesity and made clusters of metabolically healthy or metabolically unhealthy patients based on clinical and biochemical variables using two ML models. The first model showed that IR, body fat, HbA1c, red blood cells, age,ALT, uric acid, white blood cells, insulin growth factor-1, and GGT were the top predictors of a metabolically healthy obesity, revealing the importance of liver function.

    Other authors have also used ML models to classify 882 obese patients in subtypes of obesity according to glucose, insulin, and uric acid levels[116]. Results showed four stable metabolic clusters in this cohort, which were characterized by a healthy metabolic status, or by hyperuricemia, hyperinsulinemia, and hyperglycemia, respectively. Furthermore, Leeet al[117] explored three-way interactions between genome, epigenome, and dietary/lifestyle factors using GB and RF models in a subset (n= 394)of the exam 8 of the Framingham Offspring Study cohort. Interestingly, GB obtained the best performance, revealing 21 single nucleotide polymorphisms, 230 methylation sites in relevant genes(likeCPT1A,ABCG1, andSREBF1), and 26 dietary factors as top predictors for obesity. Intake of processed meat, artificially sweetened beverages, French fries, and alcohol intake, among other dietary factors, were highly associated with overweight/obesity.

    Personalized and precision medicine aims to harmonize the greatest number of factors so that diagnosis, prognosis, and treatment are based on the greatest number of decision elements. Much remains to be investigated to establish guidelines in the context of personalized medicine. However, it is safe to say that precision medicine will drive modern medicine, combining the most classic variables with the newest digital variables. Health professionals must be prepared to understand and implement these new technologies in the near future.

    CONCLUSION

    In summary, ML science can process and integrate a vast amount of different data with unprecedented outstanding performance. The objective of this article was to collect the information derived from ML techniques in liver damage induced by inflammatory conditions, including the new disease COVID-19.The main role of ML in liver pathologies is to help identify high risk patients for referral to specialized centers. Results show that the use of ML models have brought new insights into biology and medicine questions that can be very useful in determining the next directions for research in diagnosis, prognosis,and treatment of inflammatory and virus-related liver diseases, leading the way to personalized medicine. Also inflammation/IR biomarkers related to liver disease can be boosted by ML strategies.This review clarified and compiled the importance of the different factors involved in CLD and analyzed by ML algorithms, which can be useful information for clinicians, like endocrinologists and gastroenterologists, and other healthcare professionals with a focus on hepatology and bioinformatics.

    FOOTNOTES

    Author contributions:Martínez JA and Alonso-Bernáldez M contributed equally to this work as first co-authors. Martí nez JA and Ramos-Lopez O conceived and designed the study; Martínez JA, Alonso-Bernáldez M, and Ramos-Lopez O performed the search of articles and wrote the draft of the manuscript; Martínez-Urbistondo D, Vargas-Nu?ez JA,Dávalos A, and Ramos-Lopez O contributed to the analysis and critical interpretation of the data; and all authors read and approved the final manuscript.

    Supported bythe Community of Madrid and the European Union, through the European Regional Development Fund (ERDF)-REACT-EU resources of the Madrid Operational Program 2014-2020, in the action line of R + D + i projects in response to COVID-19, FACINGLCOVID-CM”; Synergic R&D Projects in New and Emerging Scientific Areas on the Frontier of Science and Interdisciplinary Nature of The Community of Madrid, METAINFLAMATIONY2020/BIO-6600.

    Conflict-of-interest statement:All the authors report no relevant conflicts of interest for this article.

    Open-Access:This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BYNC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is noncommercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

    Country/Territory of origin:Mexico

    ORCID number:J Alfredo Martínez 0000-0001-5218-6941; Ana Ramírez de Molina 0000-0003-1439-7494; Omar Ramos-Lopez 0000-0002-2505-1555.

    S-Editor:Wang JJ

    L-Editor:Filipodia

    P-Editor:Wang JJ

    18禁动态无遮挡网站| 午夜激情福利司机影院| 免费黄色在线免费观看| 国产精品蜜桃在线观看| 午夜影院在线不卡| kizo精华| 夫妻性生交免费视频一级片| 亚洲精品自拍成人| 中国三级夫妇交换| 制服人妻中文乱码| 一本大道久久a久久精品| 国产亚洲精品久久久com| 国产精品一二三区在线看| 亚洲精品一区蜜桃| 人妻一区二区av| 久久女婷五月综合色啪小说| 汤姆久久久久久久影院中文字幕| 黑人高潮一二区| 国国产精品蜜臀av免费| 少妇猛男粗大的猛烈进出视频| 夜夜骑夜夜射夜夜干| 亚洲精品成人av观看孕妇| 九九爱精品视频在线观看| 一级毛片aaaaaa免费看小| 成年人免费黄色播放视频| 国产精品.久久久| 国产免费一级a男人的天堂| 亚洲精品日韩av片在线观看| 精品久久国产蜜桃| 免费观看的影片在线观看| 一边摸一边做爽爽视频免费| 大又大粗又爽又黄少妇毛片口| 国产毛片在线视频| 国产一区二区三区综合在线观看 | 亚洲四区av| 777米奇影视久久| 精品久久久久久久久亚洲| 欧美亚洲 丝袜 人妻 在线| 国产成人精品在线电影| 99久久精品一区二区三区| 国产一区有黄有色的免费视频| 18禁观看日本| 久久久精品区二区三区| 少妇人妻精品综合一区二区| 亚洲av免费高清在线观看| 最近手机中文字幕大全| 黄色怎么调成土黄色| 精品久久国产蜜桃| 亚洲av.av天堂| 成年女人在线观看亚洲视频| 久久久久久久久久久丰满| 精品亚洲乱码少妇综合久久| 99热全是精品| 欧美3d第一页| 丰满饥渴人妻一区二区三| 少妇人妻精品综合一区二区| 99热这里只有是精品在线观看| 日韩亚洲欧美综合| 国产成人a∨麻豆精品| av一本久久久久| 爱豆传媒免费全集在线观看| 国产免费现黄频在线看| 亚洲性久久影院| 久久精品熟女亚洲av麻豆精品| 国产69精品久久久久777片| 国产亚洲一区二区精品| 欧美xxxx性猛交bbbb| 日韩亚洲欧美综合| 五月天丁香电影| 美女cb高潮喷水在线观看| 国产亚洲最大av| videos熟女内射| 午夜激情福利司机影院| 黄色视频在线播放观看不卡| 免费观看的影片在线观看| 一级a做视频免费观看| 2018国产大陆天天弄谢| 亚洲综合色网址| 一本色道久久久久久精品综合| 亚洲欧美成人综合另类久久久| 日韩伦理黄色片| 看非洲黑人一级黄片| 亚洲av成人精品一二三区| 啦啦啦在线观看免费高清www| 99久久中文字幕三级久久日本| 91久久精品国产一区二区三区| 午夜老司机福利剧场| 国产一级毛片在线| 午夜免费男女啪啪视频观看| 亚洲av欧美aⅴ国产| 十分钟在线观看高清视频www| 99热国产这里只有精品6| av天堂久久9| 亚洲欧美中文字幕日韩二区| 国产欧美日韩一区二区三区在线 | av网站免费在线观看视频| 中文字幕人妻丝袜制服| 成人亚洲精品一区在线观看| 成人国语在线视频| 午夜福利影视在线免费观看| 国产日韩欧美在线精品| 国产成人精品无人区| 亚洲国产精品专区欧美| 天堂8中文在线网| 韩国高清视频一区二区三区| 80岁老熟妇乱子伦牲交| a级毛片在线看网站| 亚洲一级一片aⅴ在线观看| 黄片播放在线免费| 一区二区三区免费毛片| 精品亚洲成a人片在线观看| 亚洲无线观看免费| 午夜av观看不卡| 精品午夜福利在线看| 国产精品嫩草影院av在线观看| 一个人免费看片子| 熟女电影av网| 99久久中文字幕三级久久日本| 欧美 亚洲 国产 日韩一| 亚洲国产精品国产精品| 久久精品国产亚洲av涩爱| 国产精品成人在线| 嫩草影院入口| 精品人妻一区二区三区麻豆| 久久久久国产网址| 日日撸夜夜添| av国产久精品久网站免费入址| 飞空精品影院首页| 国产精品国产av在线观看| 色94色欧美一区二区| 亚洲精品日韩av片在线观看| 在线观看免费高清a一片| 一边摸一边做爽爽视频免费| 欧美日韩综合久久久久久| 精品国产乱码久久久久久小说| 在线观看美女被高潮喷水网站| 在线免费观看不下载黄p国产| 国产不卡av网站在线观看| 亚洲第一区二区三区不卡| 母亲3免费完整高清在线观看 | 看免费成人av毛片| 亚洲人成网站在线观看播放| 午夜视频国产福利| 熟女av电影| 人人妻人人爽人人添夜夜欢视频| 国产色婷婷99| 另类亚洲欧美激情| 伦精品一区二区三区| 欧美激情国产日韩精品一区| videosex国产| 男的添女的下面高潮视频| 久久久久久久久大av| 国产成人av激情在线播放 | 亚洲av成人精品一区久久| 国产白丝娇喘喷水9色精品| 伊人久久精品亚洲午夜| 汤姆久久久久久久影院中文字幕| 美女福利国产在线| 狠狠精品人妻久久久久久综合| 欧美激情国产日韩精品一区| 2022亚洲国产成人精品| 一区二区三区免费毛片| 日本91视频免费播放| 久久国产精品大桥未久av| 亚洲怡红院男人天堂| 在现免费观看毛片| 精品一品国产午夜福利视频| 欧美精品人与动牲交sv欧美| 校园人妻丝袜中文字幕| 老熟女久久久| 欧美xxⅹ黑人| 国产精品欧美亚洲77777| 中文字幕av电影在线播放| 春色校园在线视频观看| 国产成人免费观看mmmm| 欧美日本中文国产一区发布| 久久久久国产网址| 亚洲第一区二区三区不卡| 满18在线观看网站| 全区人妻精品视频| 高清午夜精品一区二区三区| 亚洲欧美一区二区三区黑人 | 美女国产视频在线观看| 久久久久视频综合| 丰满迷人的少妇在线观看| 91精品国产国语对白视频| 韩国av在线不卡| 午夜福利,免费看| 国产精品成人在线| 少妇猛男粗大的猛烈进出视频| 少妇 在线观看| 国产精品国产av在线观看| 这个男人来自地球电影免费观看 | 嘟嘟电影网在线观看| 欧美激情 高清一区二区三区| 亚洲精品日韩在线中文字幕| 亚洲av电影在线观看一区二区三区| 秋霞在线观看毛片| www.av在线官网国产| 观看av在线不卡| 一区二区三区四区激情视频| 乱人伦中国视频| 国产高清不卡午夜福利| 精品午夜福利在线看| 亚洲av福利一区| 一级黄片播放器| 岛国毛片在线播放| 97在线视频观看| 国产69精品久久久久777片| 大香蕉久久网| 爱豆传媒免费全集在线观看| 少妇熟女欧美另类| 日韩一区二区视频免费看| 国产有黄有色有爽视频| 国产男女内射视频| 最近的中文字幕免费完整| 国产又色又爽无遮挡免| av在线观看视频网站免费| 青青草视频在线视频观看| 亚洲精品456在线播放app| 久久久久久久久久久免费av| 亚洲av电影在线观看一区二区三区| 晚上一个人看的免费电影| 在线观看一区二区三区激情| 看非洲黑人一级黄片| 国模一区二区三区四区视频| 国产日韩欧美在线精品| 欧美精品一区二区大全| 性色avwww在线观看| 日韩视频在线欧美| 国产 一区精品| 老司机亚洲免费影院| kizo精华| 99热网站在线观看| 下体分泌物呈黄色| 黄色配什么色好看| 国产成人91sexporn| 国产精品久久久久久精品电影小说| 久久鲁丝午夜福利片| 亚洲一级一片aⅴ在线观看| 曰老女人黄片| 久久精品熟女亚洲av麻豆精品| 欧美日韩精品成人综合77777| av国产久精品久网站免费入址| 国产免费又黄又爽又色| 少妇人妻 视频| 大香蕉97超碰在线| 中国美白少妇内射xxxbb| 制服诱惑二区| 熟女人妻精品中文字幕| 成年人免费黄色播放视频| 亚洲av成人精品一二三区| 麻豆乱淫一区二区| 夫妻性生交免费视频一级片| 一边亲一边摸免费视频| 亚洲人与动物交配视频| 国产在线视频一区二区| 在线观看三级黄色| 十八禁高潮呻吟视频| 亚洲精品aⅴ在线观看| 18禁在线播放成人免费| 婷婷成人精品国产| 国产一区有黄有色的免费视频| av在线播放精品| 69精品国产乱码久久久| 国产熟女午夜一区二区三区 | 2022亚洲国产成人精品| 亚州av有码| 黄色怎么调成土黄色| 日韩亚洲欧美综合| 啦啦啦啦在线视频资源| 美女中出高潮动态图| 国产精品国产av在线观看| 精品国产一区二区三区久久久樱花| 亚洲色图 男人天堂 中文字幕 | 久久这里有精品视频免费| 亚洲精品aⅴ在线观看| 亚洲怡红院男人天堂| 亚洲国产最新在线播放| 97超碰精品成人国产| 婷婷色综合大香蕉| 青春草亚洲视频在线观看| 十八禁高潮呻吟视频| 亚洲av中文av极速乱| 天堂8中文在线网| 免费黄频网站在线观看国产| 超色免费av| 王馨瑶露胸无遮挡在线观看| 熟女av电影| freevideosex欧美| 一本大道久久a久久精品| 亚洲精华国产精华液的使用体验| 我的女老师完整版在线观看| 婷婷色av中文字幕| 日本黄大片高清| 在线观看美女被高潮喷水网站| 中文字幕人妻熟人妻熟丝袜美| 午夜日本视频在线| 一本久久精品| 国产在线免费精品| 高清av免费在线| 性色avwww在线观看| 下体分泌物呈黄色| 最新中文字幕久久久久| 如日韩欧美国产精品一区二区三区 | 老熟女久久久| 久久久欧美国产精品| 成人毛片60女人毛片免费| 99久久中文字幕三级久久日本| 国产黄片视频在线免费观看| 热re99久久精品国产66热6| 少妇被粗大的猛进出69影院 | 在线免费观看不下载黄p国产| 波野结衣二区三区在线| 久久人人爽人人爽人人片va| 精品99又大又爽又粗少妇毛片| 国产精品一国产av| 国产精品99久久99久久久不卡 | 国产 一区精品| 最近手机中文字幕大全| 久久久久久久久久成人| 18禁在线播放成人免费| 免费少妇av软件| 精品人妻偷拍中文字幕| 人妻人人澡人人爽人人| 欧美+日韩+精品| 日本wwww免费看| 韩国高清视频一区二区三区| 制服丝袜香蕉在线| 日韩大片免费观看网站| 中文字幕人妻熟人妻熟丝袜美| 在线观看免费日韩欧美大片 | 国产白丝娇喘喷水9色精品| 久久久久视频综合| 乱码一卡2卡4卡精品| 婷婷色麻豆天堂久久| 丰满少妇做爰视频| 极品少妇高潮喷水抽搐| 久久久亚洲精品成人影院| 99久久综合免费| 亚洲欧美成人精品一区二区| 亚洲内射少妇av| 久久精品国产鲁丝片午夜精品| 久久免费观看电影| 啦啦啦中文免费视频观看日本| 建设人人有责人人尽责人人享有的| 嘟嘟电影网在线观看| 青青草视频在线视频观看| 国产免费视频播放在线视频| 国产亚洲一区二区精品| 男女无遮挡免费网站观看| 国产白丝娇喘喷水9色精品| 视频在线观看一区二区三区| 一本—道久久a久久精品蜜桃钙片| 亚洲精品,欧美精品| 一本色道久久久久久精品综合| 中文字幕av电影在线播放| 如何舔出高潮| 亚洲精品一区蜜桃| 国产伦理片在线播放av一区| 久久热精品热| 精品午夜福利在线看| 国精品久久久久久国模美| 蜜桃国产av成人99| 热99久久久久精品小说推荐| 免费观看av网站的网址| av福利片在线| 日韩强制内射视频| 国产精品一区www在线观看| 十八禁高潮呻吟视频| 夜夜看夜夜爽夜夜摸| 亚洲精品国产色婷婷电影| 狂野欧美激情性xxxx在线观看| 国产爽快片一区二区三区| 日本-黄色视频高清免费观看| 观看美女的网站| 曰老女人黄片| 搡老乐熟女国产| 一级毛片 在线播放| 黄片播放在线免费| 一边亲一边摸免费视频| 啦啦啦视频在线资源免费观看| 另类精品久久| 一个人看视频在线观看www免费| 黄片无遮挡物在线观看| 久久人人爽人人爽人人片va| 曰老女人黄片| 国产av一区二区精品久久| 久久久午夜欧美精品| 亚洲av.av天堂| 搡老乐熟女国产| 欧美丝袜亚洲另类| 亚洲国产毛片av蜜桃av| 久久久久国产网址| 女人精品久久久久毛片| 国产精品麻豆人妻色哟哟久久| 欧美人与性动交α欧美精品济南到 | 成年人午夜在线观看视频| 欧美最新免费一区二区三区| 男男h啪啪无遮挡| 国产在线视频一区二区| 久久人人爽av亚洲精品天堂| 色5月婷婷丁香| 国产亚洲最大av| 人妻一区二区av| 免费观看性生交大片5| 国产精品.久久久| 午夜91福利影院| 免费观看在线日韩| 97精品久久久久久久久久精品| 国产黄色免费在线视频| 晚上一个人看的免费电影| 一区二区av电影网| 一级爰片在线观看| 亚洲综合色网址| 国产午夜精品一二区理论片| 亚洲情色 制服丝袜| 久久鲁丝午夜福利片| 丝袜美足系列| 亚洲av日韩在线播放| 亚洲欧美一区二区三区国产| 午夜av观看不卡| 九九爱精品视频在线观看| 七月丁香在线播放| 一区二区日韩欧美中文字幕 | 狂野欧美激情性xxxx在线观看| 免费黄网站久久成人精品| 欧美xxⅹ黑人| 亚洲久久久国产精品| 国产探花极品一区二区| 91国产中文字幕| 国产高清有码在线观看视频| 在线观看www视频免费| 热99久久久久精品小说推荐| 91午夜精品亚洲一区二区三区| 免费av中文字幕在线| 春色校园在线视频观看| 国产av一区二区精品久久| 久久免费观看电影| 久久99热这里只频精品6学生| 欧美3d第一页| 日本免费在线观看一区| 午夜激情久久久久久久| 久久国产亚洲av麻豆专区| 97在线人人人人妻| 国产成人精品无人区| 综合色丁香网| 男女无遮挡免费网站观看| 国产欧美另类精品又又久久亚洲欧美| 黄色视频在线播放观看不卡| 黑丝袜美女国产一区| 亚洲色图综合在线观看| 亚洲,欧美,日韩| 狂野欧美激情性xxxx在线观看| 一级毛片aaaaaa免费看小| 永久免费av网站大全| 免费大片黄手机在线观看| 免费av中文字幕在线| 一级毛片aaaaaa免费看小| 五月玫瑰六月丁香| 在线观看人妻少妇| 国产成人免费观看mmmm| 丁香六月天网| 少妇被粗大猛烈的视频| a 毛片基地| 久久久亚洲精品成人影院| 久久精品夜色国产| 亚洲精品日韩在线中文字幕| 老司机亚洲免费影院| 日本-黄色视频高清免费观看| 日韩强制内射视频| 国产一区有黄有色的免费视频| 高清av免费在线| 精品视频人人做人人爽| 亚洲av福利一区| 亚洲av成人精品一区久久| 草草在线视频免费看| av电影中文网址| 精品人妻在线不人妻| 18禁观看日本| 九草在线视频观看| 黑人高潮一二区| 性色av一级| 精品国产一区二区三区久久久樱花| 男女高潮啪啪啪动态图| 亚洲精品中文字幕在线视频| 不卡视频在线观看欧美| 九九久久精品国产亚洲av麻豆| 亚洲综合精品二区| 男人添女人高潮全过程视频| 交换朋友夫妻互换小说| 久久青草综合色| a级毛片黄视频| 日本黄色日本黄色录像| 七月丁香在线播放| 午夜激情福利司机影院| 久久女婷五月综合色啪小说| 啦啦啦在线观看免费高清www| 丝袜在线中文字幕| 久久人妻熟女aⅴ| 日韩成人av中文字幕在线观看| 内地一区二区视频在线| 男女边摸边吃奶| 久久人人爽av亚洲精品天堂| 中文字幕制服av| 插逼视频在线观看| 国产视频首页在线观看| 女的被弄到高潮叫床怎么办| 在线观看免费视频网站a站| 久久久久久久久久人人人人人人| 中文字幕av电影在线播放| 午夜免费男女啪啪视频观看| 在线观看三级黄色| 18+在线观看网站| 日韩强制内射视频| 人妻一区二区av| 高清不卡的av网站| 亚洲精品美女久久av网站| 一级毛片电影观看| 十八禁网站网址无遮挡| 嫩草影院入口| 欧美日韩一区二区视频在线观看视频在线| 国产亚洲精品久久久com| 中文字幕人妻丝袜制服| 国模一区二区三区四区视频| 中文字幕人妻丝袜制服| 成年人午夜在线观看视频| 久久热精品热| 51国产日韩欧美| 汤姆久久久久久久影院中文字幕| 另类精品久久| 看非洲黑人一级黄片| 纯流量卡能插随身wifi吗| freevideosex欧美| 妹子高潮喷水视频| 精品国产乱码久久久久久小说| 亚洲图色成人| 肉色欧美久久久久久久蜜桃| 一区二区三区乱码不卡18| 女人久久www免费人成看片| 好男人视频免费观看在线| 免费高清在线观看日韩| 成年人午夜在线观看视频| a级毛片在线看网站| 国产成人aa在线观看| 久久99精品国语久久久| 18禁动态无遮挡网站| 亚洲av日韩在线播放| 午夜福利影视在线免费观看| 中文天堂在线官网| 99热6这里只有精品| 如日韩欧美国产精品一区二区三区 | 超色免费av| 999精品在线视频| 国产精品一国产av| 国产乱来视频区| 少妇丰满av| 乱码一卡2卡4卡精品| 一级片'在线观看视频| 国产亚洲精品第一综合不卡 | 免费不卡的大黄色大毛片视频在线观看| 亚洲欧美色中文字幕在线| 男女边吃奶边做爰视频| kizo精华| 日韩成人av中文字幕在线观看| 国产成人精品无人区| 99热全是精品| 看非洲黑人一级黄片| 丝瓜视频免费看黄片| 男女国产视频网站| www.av在线官网国产| 人妻人人澡人人爽人人| 女人久久www免费人成看片| 国产在视频线精品| 久久久久久久久久久久大奶| 51国产日韩欧美| 欧美日韩视频精品一区| 蜜桃久久精品国产亚洲av| 97超视频在线观看视频| av视频免费观看在线观看| 少妇被粗大猛烈的视频| 久久精品国产鲁丝片午夜精品| 国产国拍精品亚洲av在线观看| 日韩成人伦理影院| 久久国产亚洲av麻豆专区| 黄色一级大片看看| 一本一本综合久久| 最新的欧美精品一区二区| 五月天丁香电影| 精品国产一区二区久久| 夜夜爽夜夜爽视频| 国产综合精华液| 在线精品无人区一区二区三| 五月天丁香电影| 只有这里有精品99| 高清在线视频一区二区三区| 极品人妻少妇av视频| 日日摸夜夜添夜夜添av毛片| 免费观看性生交大片5| 国产av码专区亚洲av| 精品人妻熟女av久视频| 日韩制服骚丝袜av| 在线观看免费视频网站a站| 在线观看国产h片| 制服丝袜香蕉在线| 免费看av在线观看网站| 观看av在线不卡| 80岁老熟妇乱子伦牲交| 黄色毛片三级朝国网站| 亚洲精品日韩在线中文字幕| 天天影视国产精品| 久久女婷五月综合色啪小说| 亚洲国产最新在线播放| 一区在线观看完整版| 热99久久久久精品小说推荐|